
After 3 exceptionally successful diabetic foot ulcer treatment pivotal trials, Circularity Healthcare is in expanded pivotal trials for updated FDA clearance with D’OXYVA®
After three exceptionally successful diabetic foot ulcer pivotal trials, Circularity Healthcare is in expanded pivotal trials for updated FDA clearance with its D’OXYVA® (deoxyhemoglobin vasodilator) noninvasive transdermal drug delivery system at 18 of the 20 top-ranked U.S. universities for becoming a universal treatment for diabetic










